* In the event the class of drugs specified herein has previously been reviewed, the government solicits quotes for new BPAs/VARRs to replace any
existing BPAs/VARRs . The government will not consider existing BPA/VARR prices in the
UF evaluation. Any existing BPA/VARR for this class of drugs will be terminated
upon the conclusion of the UF decision.